June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Morphological Analysis of Type 1, Type 2, and Type 3 Neovascularization in Exudative Age-Related Macular Degeneration using OCT Angiography
Author Affiliations & Notes
  • Aaron Nagiel
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Mayank Bansal
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Tamara Lenis
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Talisa de Carlo
    Ophthalmology, Tufts University School of Medicine, Boston, MA
  • Marco A Filho Bonini
    Ophthalmology, Tufts University School of Medicine, Boston, MA
    Ministry of Education, Brasilia, Brazil
  • Yan Sheng
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Nadia K Waheed
    Ophthalmology, Tufts University School of Medicine, Boston, MA
  • David Sarraf
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Footnotes
    Commercial Relationships Aaron Nagiel, None; Mayank Bansal, None; Tamara Lenis, None; Talisa de Carlo, None; Marco Bonini, None; Yan Sheng, None; Nadia Waheed, None; David Sarraf, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3965. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aaron Nagiel, Mayank Bansal, Tamara Lenis, Talisa de Carlo, Marco A Filho Bonini, Yan Sheng, Nadia K Waheed, David Sarraf; Morphological Analysis of Type 1, Type 2, and Type 3 Neovascularization in Exudative Age-Related Macular Degeneration using OCT Angiography. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3965.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To describe and compare the morphological structure of Type 1, Type 2, and Type 3 neovascularization in exudative age-related macular degeneration (AMD) using optical coherence tomography (OCT) angiography.

 
Methods
 

This was a retrospective, cross-sectional, observational study of patients with neovascular AMD. All patients underwent imaging with spectral-domain OCT and OCT angiography (Optovue AngioVue System). Type 1, 2, and 3 neovascularization was identified with high-resolution spectral-domain OCT and the correlative anatomical features of these lesions were then studied using OCT angiography.

 
Results
 

A total of 31 eyes of 26 patients with neovascular AMD were imaged with structural and flow-based OCT protocols. Type 1 (sub-retinal pigment epithelium; sub-RPE) neovascular membranes associated with vascularized pigment epithelial detachments (PEDs) or chronic multilayered PEDs were identified in 23 eyes. Type 2 (subretinal) neovascularization was found in 1 eye, and Type 3 neovascularization (retinal angiomatous proliferation; RAP) was studied in 8 eyes. In every case of Type 1 neovascularization, a plaque of thick vessels beneath the RPE could be identified regardless of whether there was associated intraretinal, subretinal, or sub-RPE fluid. In eyes with chronic multilayered PEDs, these vessels could be identified along the RPE monolayer above an organized scar. Type 2 neovascularization demonstrated a bright spoke-wheel arrangement of subretinal vessels that corresponded to a hyper-reflective plaque on structural OCT. Type 3 neovascularization varied in OCT angiographic appearance with 2 cases demonstrating sub-RPE vessels, 3 cases showing a focal tuft of fine vessels at the level of the RPE, and two without detectable vessels. These distinct manifestations appeared to be independent of the activity of the lesion, the treatment status, or the presence of fluid.

 
Conclusions
 

OCT angiography is a new imaging modality capable of revealing the morphological structure of Type 1, Type 2, and Type 3 neovascularization in exudative AMD. Studies are ongoing to detect anatomic features that indicate neovascular activity and how these may be altered with treatment.  

 
Type 1 neovascular membrane beneath a chronic multilayered PED with overlying subretinal fluid.
 
Type 1 neovascular membrane beneath a chronic multilayered PED with overlying subretinal fluid.
 
 
Type 2 neovascular membrane above the RPE with a spoke-wheel arrangment of vessels.
 
Type 2 neovascular membrane above the RPE with a spoke-wheel arrangment of vessels.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×